Immunogenicity and Safety of a Cell Culture-Derived Inactivated Quadrivalent Influenza Vaccine (NBP607-QIV) in South Korean Children and Adolescents: A Randomized, Double-Blind, Multi-Center, Phase 3 Clinical Trial
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.